JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB235878

Recombinant Human DR6 protein (Fc tag C-Terminus + His tag C-Terminus)

Be the first to review this product! 리뷰 제출

|

(0 출판물)

Recombinant Human DR6 protein (Fc tag C-Terminus + His tag C-Terminus) is a Human Fragment protein, in the 42 to 349 aa range, expressed in Baculovirus infected insect cells, with >85%, < 1 EU/µg endotoxin level, suitable for SDS-PAGE.

대체 명칭 보기

CD358, DR6, UNQ437/PRO868, TNFRSF21, Tumor necrosis factor receptor superfamily member 21, Death receptor 6

1 이미지
SDS-PAGE - Recombinant Human DR6 protein (Fc tag C-Terminus + His tag C-Terminus) (AB235878)
  • SDS-PAGE

Supplier Data

SDS-PAGE - Recombinant Human DR6 protein (Fc tag C-Terminus + His tag C-Terminus) (AB235878)

15% SDS-PAGE analysis of 3 μg ab235878.

50-70 kDa (Under reducing conditions)

주요 정보

Purity

>85% SDS-PAGE

Affinity purified

Endotoxin 레벨

< 1 EU/µg

발현 시스템

Baculovirus infected insect cells

Tags

Fc tag C-Terminus His tag C-Terminus

Applications

SDS-PAGE

applications

Biologically active

No

Accession

Animal free

No

Carrier free

No

Species

Human

보관 버퍼

pH: 7.4 Constituents: PBS, 10% Glycerol (glycerin, glycerine), 0.002% PMSF

storage-buffer

Reactivity 정보

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "SDS-PAGE": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

서열 정보

[{"linker":null,"sequence":"QPEQKASNLIGTYRHVDRATGQVLTCDKCPAGTYVSEHCTNTSLRVCSSCPVGTFTRHENGIEKCHDCSQPCPWPMIEKLPCAALTDRECTCPPGMFQSNATCAPHTVCPVGWGVRKKGTETEDVRCKQCARGTFSDVPSSVMKCKAYTDCLSQNLVVIKPGTKETDNVCGTLPSFSSSTSPSPGTAIFPRPEHMETHEVPSSTYVPKGMNSTESNSSASVRPKVLSSIQEGTVPDNTSSARGKEDVNKTLPNLQVVNHQQGPHHRHILKLLPSMEATGGEKSSTPIKGPKRGHPRQNLHKHFDINEHLEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGKHHHHHH","proteinLength":"Fragment","predictedMolecularWeight":"60.4 kDa","actualMolecularWeight":null,"aminoAcidEnd":349,"aminoAcidStart":42,"nature":"Recombinant","expressionSystem":"Baculovirus infected insect cells","accessionNumber":"O75509","tags":[{"tag":"Fc","terminus":"C-Terminus"},{"tag":"His","terminus":"C-Terminus"}]}]

특성 및 보관 정보

제형
Liquid
Purification 테크닉
Affinity purification
배송 시 보관 조건
Blue Ice
적절한 단기 보관 기간
1-2 weeks
적절한 단기 보관 조건
+4°C
적절한 장기 보관 조건
-20°C
분주 정보
Upon delivery aliquot
보관 정보
Avoid freeze / thaw cycle
False

추가 정보

This supplementary information is collated from multiple sources and compiled automatically.

DR6 also known as Death Receptor 6 or TNFRSF21 is a member of the tumor necrosis factor receptor superfamily. This protein has a mass of approximately 71 kDa and is expressed in a variety of tissues including the heart lymph nodes and spleen. DR6 functions as a transmembrane receptor and plays a critical role in mediating apoptosis and cellular communication.
Biological function summary

DR6 acts as a mediator in cell death signaling pathways. It associates with other proteins to form a death-inducing signaling complex triggering apoptotic pathways upon activation by specific ligands. DR6 is involved in regulating cell growth differentiation and survival. It also plays a role in modulating the immune response especially the adaptive immune response by influencing T-cell activation and proliferation.

Pathways

DR6 is involved in apoptosis and immune signaling pathways. It interacts with proteins such as caspases and adaptor proteins in the apoptotic pathways. In the immune system DR6 is related to proteins like TRAF family members which help in transmitting signals required for T-cell responses. DR6 influences several downstream effects that are critical for maintaining cellular homeostasis and immune regulation.

DR6 has been implicated in neurodegenerative diseases and cancer. Altered expression or function of DR6 can contribute to diseases such as Alzheimer's disease by promoting neuronal apoptosis. In cancer aberrant DR6 signaling may affect tumor cell survival and progression. DR6's interaction with amyloid precursor protein (APP) in neurodegenerative diseases and its association with certain tumor necrosis factor ligands in cancer highlight its significance in disease pathways.

일반 정보

기능

Promotes apoptosis, possibly via a pathway that involves the activation of NF-kappa-B. Can also promote apoptosis mediated by BAX and by the release of cytochrome c from the mitochondria into the cytoplasm. Trophic-factor deprivation triggers the cleavage of surface APP by beta-secretase to release sAPP-beta which is further cleaved to release an N-terminal fragment of APP (N-APP). Negatively regulates oligodendrocyte survival, maturation and myelination. Plays a role in signaling cascades triggered by stimulation of T-cell receptors, in the adaptive immune response and in the regulation of T-cell differentiation and proliferation. Negatively regulates T-cell responses and the release of cytokines such as IL4, IL5, IL10, IL13 and IFNG by Th2 cells. Negatively regulates the production of IgG, IgM and IgM in response to antigens. May inhibit the activation of JNK in response to T-cell stimulation. Also acts as a regulator of pyroptosis : recruits CASP8 in response to reactive oxygen species (ROS) and subsequent oxidation, leading to activation of GSDMC (PubMed : 34012073).

Post-translational modifications

Oxidized in response to reactive oxygen species (ROS), leading to endocytosis.

제품 프로토콜

타겟 정보

Promotes apoptosis, possibly via a pathway that involves the activation of NF-kappa-B. Can also promote apoptosis mediated by BAX and by the release of cytochrome c from the mitochondria into the cytoplasm. Trophic-factor deprivation triggers the cleavage of surface APP by beta-secretase to release sAPP-beta which is further cleaved to release an N-terminal fragment of APP (N-APP). Negatively regulates oligodendrocyte survival, maturation and myelination. Plays a role in signaling cascades triggered by stimulation of T-cell receptors, in the adaptive immune response and in the regulation of T-cell differentiation and proliferation. Negatively regulates T-cell responses and the release of cytokines such as IL4, IL5, IL10, IL13 and IFNG by Th2 cells. Negatively regulates the production of IgG, IgM and IgM in response to antigens. May inhibit the activation of JNK in response to T-cell stimulation. Also acts as a regulator of pyroptosis : recruits CASP8 in response to reactive oxygen species (ROS) and subsequent oxidation, leading to activation of GSDMC (PubMed : 34012073).
See full target information TNFRSF21

Product promise

저희는 고품질 시약으로 고객님의 연구를 서포트하고자 최선을 다하고 있으며, 모든 단계에서 함께 하겠습니다. 만약 제품이 기대한 성능을 보이지 않을 경우에도 Product Promise로 보호받으실 수 있습니다.
자세한 내용은 이용 약관을 확인해 주세요.

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com